Cargando…

Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates

BACKGROUND: Bisphosphonates are indicated in the prevention and treatment of osteoporosis. However, bone mineral density (BMD) continues to decline in up to 15% of bisphosphonate users. While randomized trials have evaluated the efficacy of concurrent bisphosphonates and vitamin D, the incremental b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heckman, George A, Papaioannou, Alexandra, Sebaldt, Rolf J, Ioannidis, George, Petrie, Annie, Goldsmith, Charlie, Adachi, Jonathan D
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2002
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC65678/ https://www.ncbi.nlm.nih.gov/pubmed/11860614 http://dx.doi.org/10.1186/1471-2474-3-6

Ejemplares similares

The association between iliocostal distance and the number of vertebral and non-vertebral fractures in women and men registered in the Canadian Database For Osteoporosis and Osteopenia (CANDOO)
por: Olszynski, WP, et al.
Publicado: (2002)

The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women
por: Adachi, Jonathan D, et al.
Publicado: (2002)

Additive effects of eldecalcitol in poorly responding long-term bisphosphonate treatment for osteoporosis
por: Kamimura, Mikio, et al.
Publicado: (2019)

Evaluation of easily measured risk factors in the prediction of osteoporotic fractures
por: Bensen, Robert, et al.
Publicado: (2005)

Influence of Vitamin K on Bone Mineral Density and Osteoporosis
por: Elshaikh, Abeer O, et al.
Publicado: (2020)

Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study
por: Grima, Daniel T, et al.
Publicado: (2010)

An overview of osteoporosis and frailty in the elderly
por: Li, Guowei, et al.
Publicado: (2017)

Influence of vitamin D levels on bone mineral density and osteoporosis
por: Sadat-Ali, Mir, et al.
Publicado: (2011)

Comparison between teriparatide and bisphosphonates for improving bone mineral density in postmenopausal osteoporosis patients: A meta-analysis
por: Fan, Guiyong, et al.
Publicado: (2020)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

The Effects of Noncompliance to Prolia (Denosumab) on the Changes in Bone Mineral Density: A Retrospective Review
por: Wong-Pack, Matthew, et al.
Publicado: (2016)

The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis
por: Deane, Andrew, et al.
Publicado: (2007)

Exploring participant attrition in a longitudinal follow-up of older adults: the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton cohort
por: Okpara, Chinenye, et al.
Publicado: (2023)

Characterizing the Assessment and Management of Vitamin D Levels in Patients with Osteoporosis in Clinical Practice: A Chart Review Initiative
por: Adachi, Jonathan D., et al.
Publicado: (2015)

The osteoporosis care gap in Canada
por: Papaioannou, A, et al.
Publicado: (2004)

Parathyroid Hormone versus Bisphosphonate Treatment on Bone Mineral Density in Osteoporosis Therapy: A Meta-Analysis of Randomized Controlled Trials
por: Shen, Longxiang, et al.
Publicado: (2011)

Combination therapy of anabolic agents and bisphosphonates on bone mineral density in patients with osteoporosis: a meta-analysis of randomised controlled trials
por: Lou, Shenghan, et al.
Publicado: (2018)

Osteoporosis in Canadian adult cystic fibrosis patients: A descriptive study
por: Brenckmann, Christine, et al.
Publicado: (2003)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Bisphosphonates adherence for treatment of osteoporosis
por: Vieira, Helena Parente, et al.
Publicado: (2013)

Histomorphometry of Bone Microarchitecture in Rats Treated with Vitamin D and Bisphosphonate in the Management of Osteoporosis
por: Queiroz Júnior, José Reginaldo Alves de, et al.
Publicado: (2022)

Effect of Vitamin D Supplementation on Bone Mineral Density in Rheumatoid Arthritis Patients With Osteoporosis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Frailty index of deficit accumulation and falls: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton cohort
por: Li, Guowei, et al.
Publicado: (2014)

Comparison between Frailty Index of Deficit Accumulation and Phenotypic Model to Predict Risk of Falls: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton Cohort
por: Li, Guowei, et al.
Publicado: (2015)

Vitamin D receptor gene polymorphisms, bone mineral density and fractures in postmenopausal women with osteoporosis
por: Horst-Sikorska, Wanda, et al.
Publicado: (2012)

Vitamin D Boosts Alendronate Tail Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis
por: Catalano, Antonino, et al.
Publicado: (2021)

Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015)

Long-term use of bisphosphonates in osteoporosis
por: Sadat-Ali, Mir, et al.
Publicado: (2017)

Long-term use of bisphosphonates in osteoporosis
por: Alwahhabi, Basmah K., et al.
Publicado: (2017)

Strontium ranelate effect on bone mineral density is modified by previous bisphosphonate treatment
por: Brun, Lucas R, et al.
Publicado: (2014)

Effects of Bisphosphonate Therapy on Bone Mineral Density in Boys with Duchenne Muscular Dystrophy
por: Ronsley, Rebecca, et al.
Publicado: (2020)

Optimizing care in osteoporosis: The Canadian quality circle project
por: Ioannidis, George, et al.
Publicado: (2008)

Associations between Social Isolation Index and changes in grip strength, gait speed, bone mineral density (BMD), and self-reported incident fractures among older adults: Results from the Canadian Longitudinal Study on Aging (CLSA)
por: Lee, Ahreum, et al.
Publicado: (2023)

The Influence of Vitamin D Receptor Genetic Variants on Bone Mineral Density and Osteoporosis in Chinese Postmenopausal Women
por: He, Wei, et al.
Publicado: (2015)

The effects of minodronate and activated vitamin D on bone mineral density and muscle mass in postmenopausal women with osteoporosis
por: Fujimoto, Kazuki, et al.
Publicado: (2018)

The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer
por: Al-Shamsi, Humaid O., et al.
Publicado: (2012)

The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC)
por: Ioannidis, George, et al.
Publicado: (2009)

Differences between the bisphosphonates for the prevention and treatment of osteoporosis
por: Grey, Andrew, et al.
Publicado: (2006)

Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
por: Villa, Alessandro, et al.
Publicado: (2011)

Patient preference in the management of postmenopausal osteoporosis with bisphosphonates
por: Reginster, Jean-Yves, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_k4tq94q7ecr5phd11fc1l04nui